Severe Acute Respiratory Syndrome
Showing 1 - 25 of >10,000
Severity of Severe Acute Respiratory Syndrome COVID-19 Infection
Completed
- COVID-19
- +3 more
- No Intervention
-
Colton, CaliforniaArrowhead Regional Medical Center
Jun 7, 2023
Severe Acute Respiratory Syndrome (SARS), Acute Respiratory Distress Syndrome (ARDS), Pneumonia Trial in Salvador (intravenous
Not yet recruiting
- Severe Acute Respiratory Syndrome (SARS)
- +2 more
- intravenous treatment with EVs
- intravenous treatment with placebo solution
-
Salvador, Bahia, BrazilHospital São Rafael
Aug 18, 2023
Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (Disorder) Trial (MBS-COV, Placebo)
Not yet recruiting
- Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (Disorder)
- MBS-COV
- Placebo
- (no location specified)
Jul 11, 2023
Assess Infection Rate of Severe Acute Respiratory Syndrome -
Completed
- Severe Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2)
-
Chicago, IllinoisGreat Lakes Clinical Trials /ID# 224874
Oct 6, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Trial in Ferrara (SARS-Cov-2 infection)
Recruiting
- Severe Acute Respiratory Syndrome Coronavirus 2
- SARS-Cov-2 infection
-
Ferrara, ItalyAzienda Ospedaliera Universitaria di Ferrara
Nov 1, 2022
Antigen Rapid Diagnostic Tests for Community Identification of
Recruiting
- Severe Acute Respiratory Syndrome Coronavirus 2 Infection
- Rapid Antigen Testing
-
Kiambu, KenyaKiambu County
Jul 12, 2022
Anti-COVID-19 Humoral and Memory T Cell Responses in Various
Active, not recruiting
- Immune Response
- blood collection
-
Paris, FranceHôpital Robert Debré
Sep 15, 2022
Anosmia Trial (platelets rich plasma)
Not yet recruiting
- Anosmia
- platelets rich plasma
- (no location specified)
May 25, 2022
Pulmonary Fibrosis During Severe COVID-19 Pneumonia
Active, not recruiting
- Severe Acute Respiratory Syndrome Coronavirus 2
- +2 more
- Aminoterminal type III peptide of procollagen
- Lung computed tomography
-
Marseille, FranceHopital Europeen Marseille
Aug 7, 2022
How Future Surgery Will Benefit From Severe Acute Respiratory
Completed
- COVID-19
- Health Behavior
- COVID-surg-SPIGC questionnaire
-
Roma, Rome, Italy
- +2 more
Nov 17, 2022
SARS (Severe Acute Respiratory Syndrome) Trial in Sousse, Sahloul (Quercetin, Placebo)
Completed
- SARS (Severe Acute Respiratory Syndrome)
- Quercetin
- Placebo
-
Sousse, Itinéraire Ceinture Cité Sahloul, Tunisia
- +1 more
Jan 2, 2023
a Randomized Double-blind Study, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), PHYTOTHERAPIE Trial in Sahloul
Completed
- a Randomized Double-blind Study
- +2 more
-
Sahloul, Sousse, TunisiaRiadh Boukef
Jan 2, 2023
SARS (Severe Acute Respiratory Syndrome), Coronavirus Trial in Sweden, United States (Nitric Oxide Gas)
Completed
- SARS (Severe Acute Respiratory Syndrome)
- Coronavirus
- Nitric Oxide Gas
-
Birmingham, Alabama
- +4 more
Jun 20, 2022
Japan After Severe Acute Respiratory Syndrome Coronavirus 2
Not yet recruiting
- SARS-CoV-2
-
Tokyo, JapanCMIC Co., Ltd
Jun 6, 2023
Severe Exacerbation of Severe Acute Respiratory Syndrome
Active, not recruiting
- SARS-CoV-2
-
Tokyo, JapanCMIC Co. Ltd.,
Jun 5, 2023
Covid19, Hypertension, Corona Persistent Symptoms Trial in Giza (Inspiratory muscle trainer, diaphragmatic release)
Enrolling by invitation
- Covid19
- +2 more
- Inspiratory muscle trainer
- diaphragmatic release
-
Giza, Dokki, EgyptFaculty of Physical Therapy
Jun 17, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Infection Trial (COVAC-1, Saline Placebo)
Not yet recruiting
- Severe Acute Respiratory Syndrome Coronavirus 2 Infection
- COVAC-1
- Saline Placebo
- (no location specified)
Jan 23, 2023
Clinical Features of COVID-19 Patients
Recruiting
- Covid19
- +2 more
- peripheral lymphocytes subsets
-
L'Aquila, ItalySan Salvatore Academic Hospital
Oct 25, 2022
Non-invasive Respiratory Support on Outcome and Its Risks in
Active, not recruiting
- COVID-19
- Hypoxemic Respiratory Failure
- High flow nasal oxygen (HFNO, more than 15 L/min)
-
Rotterdam, Zuid-Holland, NetherlandsErasmus MC
Sep 4, 2023
Non-invasive Oxygenation Strategies in Patients Admitted for
Completed
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- Use of High Flow Nasal Cannula alone
- +2 more
-
Béthune, Nord-Pas-de-Calais, France
- +3 more
Oct 10, 2022
SARS (Severe Acute Respiratory Syndrome), Cytokine Storm, ARDS, Human Trial in Germany, Sweden (Hyperbaric oxygen)
Terminated
- SARS (Severe Acute Respiratory Syndrome)
- +5 more
- Hyperbaric oxygen
-
Regensburg, Germany
- +2 more
Jan 5, 2023
Covid19 Trial in Nedlands (anti-SARS-CoV-2 IgY, Placebo)
Completed
- Covid19
- anti-SARS-CoV-2 IgY
- Placebo
-
Nedlands, Western Australia, AustraliaLinear Clinical Research - Harry Perkins Research Institute
Jun 30, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in
Not yet recruiting
- Systemic Sclerosis
- SARS-CoV 2 Vaccination
- (no location specified)
Jul 24, 2023
Acute Respiratory Distress Syndrome, Ventilator Lung Trial in Rotterdam (Flow-controlled ventilation)
Not yet recruiting
- Acute Respiratory Distress Syndrome
- Ventilator Lung
- Flow-controlled ventilation
-
Rotterdam, Zuid-Holland, NetherlandsMaasstad Hospital
Sep 20, 2023
Respiratory Distress Syndrome, Mechanical Ventilation, SARS (Severe Acute Respiratory Syndrome) Trial in São Paulo (EIT-Group,
Recruiting
- Respiratory Distress Syndrome
- +2 more
- EIT-Group
- ARDSNet
-
São Paulo, BrazilUSP Instituto do Coração
May 5, 2022